Talk:Ondansetron
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Ondansetron.
|
| This is the talk page for discussing improvements to the Ondansetron article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 60 days  |
 | This article is rated B-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||
| |||||||||||||||||||||
Ototoxicity claim
editRevision 603253509 added the claim that, anecdotally, IV ondansetron is linked with ototoxicity when administered too quickly. This revision had no source for the claim. A source was later added, but this source makes no mention of ototoxicity in either the archived or present versions. I was also unable to find anything in the scientific literature about ototoxicity; the closest I came to a supporting source was an article on ototoxic drugs that had a list of drugs reported to cause vertigo or dizziness as a side effect, which is not the same as ototoxicity. I opted to remove the claim rather than mark it as needing a citation especially given that the claim itself is presented as anecdotal, but I'm noting the removal here in case someone happens to know of a supporting source. NoelleLavenza (talk) 00:41, 14 May 2024 (UTC)